Comment
doi: 10.1001/jamainternmed.2018.3025.
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World
Affiliations
- PMID: 30105365
- DOI: 10.1001/jamainternmed.2018.3025
Item in Clipboard
Comment
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World
JAMA Intern Med.
.
No abstract available
Comment on
-
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.JAMA Intern Med. 2018 Sep 1;178(9):1190-1198. doi: 10.1001/jamainternmed.2018.3034. JAMA Intern Med. 2018. PMID: 30105373 Free PMC article.
Similar articles
-
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.JAMA Intern Med. 2018 Sep 1;178(9):1190-1198. doi: 10.1001/jamainternmed.2018.3034. JAMA Intern Med. 2018. PMID: 30105373 Free PMC article.
-
Sodium-Glucose Cotransporter 2 Inhibitors and Amputations.JAMA Intern Med. 2019 Mar 1;179(3):451-452. doi: 10.1001/jamainternmed.2018.8134. JAMA Intern Med. 2019. PMID: 30830185 No abstract available.
-
Real-world risk of lower-limb amputation associated with sodium-glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in Japan.J Diabetes Investig. 2022 Dec;13(12):2000-2009. doi: 10.1111/jdi.13906. Epub 2022 Sep 19. J Diabetes Investig. 2022. PMID: 36124433 Free PMC article.
-
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Amputation: What Is Currently Known?Am J Ther. 2020 Mar 18;28(1):e96-e110. doi: 10.1097/MJT.0000000000001164. Am J Ther. 2020. PMID: 32384319 Review.
-
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk.Heart Fail Clin. 2022 Oct;18(4):645-654. doi: 10.1016/j.hfc.2022.03.008. Heart Fail Clin. 2022. PMID: 36216493 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
